Oleksandr Kondratov is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant adeno-associated viruses (rAAV). With a total of 2 patents, his work focuses on enhancing the biological potency of viral systems for therapeutic applications.

Latest Patents

Kondratov's latest patents include innovative methods for enhancing the biological potency of baculovirus system-produced recombinant adeno-associated virus. These patents provide methods and compositions that are useful in the production of rAAV in host producer cells, such as insect cells. In particular, his work involves the use of modified Kozak sequences to express AAV VP1 proteins in amounts that are beneficial for producing infective rAAV particles. These particles can carry a gene of interest, making them valuable for gene therapy applications.

Career Highlights

Kondratov is affiliated with the University of Florida Research Foundation, Incorporated, where he continues to advance research in viral vector technology. His expertise in the field has positioned him as a key figure in the development of innovative solutions for gene delivery systems.

Collaborations

One of his notable collaborators is Sergei Zolotukhin, with whom he has worked on various projects related to recombinant virus production. Their combined efforts have contributed to the advancement of methodologies in the field.

Conclusion

Oleksandr Kondratov's work in the production of recombinant adeno-associated viruses represents a significant advancement in biotechnology. His innovative approaches and collaborations continue to pave the way for future developments in gene therapy.

This text is generated by artificial intelligence and may not be accurate.